Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Cancidas 50mg powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) |
| BNF code | 0502040C0BBAAAA |
| Virtual Medicinal Product | Caspofungin 50mg powder for solution for infusion vials |
| Name | Cancidas 50mg powder for concentrate for solution for infusion vials |
| Abbreviated name | Cancidas 50mg pdr for concentrate for inf vials |
| Date of name applicability | 17 Nov 2023 |
| Previous name | Cancidas 50mg powder for solution for infusion vials |
| Supplier | Merck Sharp & Dohme (UK) Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Cancidas 50mg powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.